Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

Search Filters

ACC Houston Healthcare Law Practice Group CLE Webinar
COVID-19 Vaccination Mandates - Special Issues for the Health Care Industry
October 26, 2021 | 12 pm - 1 pm | 1.00 hours CLE (TX)

Employers everywhere are struggling with whether and how to implement a mandate for their employees to be vaccinated against COVID-19. The issue is especially acute in the health care industry. This webinar will discuss the fundamental legal principles and practical implications of such a mandate in a health care setting.

Andrew Hii, Partner, and Meaghan Powell, Lawyer, Gilbert + Tobin
3 pages

At a recently panel discussion in which the panelists discussed the prevailing local and global trends in the healthcare sector, with a particular focus on the future of healthcare and the significance of data governance. This article summarizes the key discussion points of the panel discussion.

Resource Details
Interest Area: Health Law
Region: Australia
Audience: Mid-Career, New to In-House
Luci Mumme, Partner, and Louise Russell, Special Counsel, Johnson, Winter & Slattery
2 pages

This article provides insight into amendments made to the Work Health & Safety Act 2011 (Qld), which was amended previously to provide for the offense of industrial manslaughter. It was later amended in 2020 to cover the resources sector including coal. The piece also provides analysis and key issues for the 2020 amendment of the law.

Resource Details
Interest Area: Health Law, Government
Region: Australia
Audience: Deputy GC, CLO / GC, Small Law Departments, Large Law Departments
Christine Ecob, Partner, and Stanley Yu, Senior Associate, Johnson, Winter & Slattery
2 pages

This article provides an analysis on laws pertaining to apps that are used for treating, diagnosing, or monitoring a condition. Specifically, these kinds of apps are likely to be subject to stricter pre-market requirements under newly implemented reforms.

Resource Details
Region: Australia
Audience: Deputy GC, Mid-Career
Foley & Lardner LLP
16 pages

This sample form provides a Research Misconduct Policy that assists research staff members to establish and maintain high standards of ethical practices in research. The form contains policy that describes ongoing obligations of research staff to promote an environment that supports ethical research and process.

Resource Details
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Foley & Lardner LLP
10 pages

This checklist can be used as a starting point for assessing legal issues in negotiation for software/technology services from a Buyer's standpoint. 

Resource Details
Region: United States
Audience: Mid-Career, New to In-House, Small Law Departments, Large Law Departments
Foley & Lardner LLP
3 pages

This checklist contains a sample list of questions that can be used as a starting point for conducting due diligence from a privacy and security standpoint.

Resource Details
Region: United States
1 person found this helpful.
Session I, 9:30 a.m. to 10:30 a.m. – IP Pledge of Allegiance: Your Intellectual Property Now and After Taking the Open COVID Pledge

 

Created by a worldwide team of scientists, business leaders, and attorneys, the Open COVID Pledge is a platform to license patents and copyrights freely to aid in the COVID-19 fight.  But, if you make the pledge, how does it affect your IP now and more crucially after the pandemic ends?

 
Break — 10:30 to 11:00 a.m.
 
Session II, 11:00 a.m. to 12:00 p.m. – Counseling During The New Normal: Lessons Learned From Going Remote During COVID-19

 

Join our expert panelists as they discuss adapting to counseling during this new phase of the COVID-19 pandemic.  The panel will discuss FDA safety inspections, clinical trial oversight, and HCP speaker programs, as they assess how COVID-19 shutdowns changed the regulatory risks facing pharmaceutical and device manufacturers, and how those risks can be minimized as companies take their next steps.

 

Click the red button below to RSVP.

 

Join in by following this Zoom link:
Foley & Larder LLP
28 pages

This “Guide” is not meant to be an exhaustive analysis of the return-to-the-office situation post-Covid; rather, it should be used as a starting point for employers to create or update their policies and practices in conjunction with a thorough analysis of all applicable laws, ordinances, and guidance. 

Resource Details
Region: United States
Audience: Deputy GC, CLO / GC, Small Law Departments, Large Law Departments
Subscribe to Health Law
ACC